Académique Documents
Professionnel Documents
Culture Documents
A)
Drug Establishment
B)
-Involved in manuf, importation, repacking, &/or
Other functions:
distribution
• Handles research activities (market,
Types of Drug Establishment
pharmaceutical, chemical,
I) Manufacturer - refers to any establishment pharmacological, biological, clinical)
engaged in the operations involved in the
3 required Facilities:
production of a drug with the end view of
storage, distribution, or sale of the product L
I-A) Ethical manufacturers (ex: Jantoven, A
Inderal)
P
I-B) Proprietary
2) PRODUCTION Department
I-C) Biologicals Manufacturers (ex: Dengvaxia)
• receives materials and supplies
I-D) Veterinary Product Manufacturers
• oversees warehousing and storage and
I-E) Medical/Chemical shipping of the final product to
customers
I-F) ________________ – an arrangement
whereby a competent company processes raw • manufactures and packages products
materials or semi-finished goods, or packages
products for another company • exercises production, personnel,
labeling and packaging control.
Examples: __________ and __________
• ________________________________
II) Drug trader –__________________ of the
drug product (may subcontract to a toll) 3) QUALITY CONTROL Department
1)___________ 2)___________
• clinical pharmacology
5. NDA
Therapeutic Indication:
• Standard Operating Procedures (SOPs) A) One year after the expiration date of
–______________________ for the product
performing operational tasks/activities OR
B) 3 years after the distribution of the
• Manufacturing Order –is a document
product
which just gives instructions to the
production dept to produce a products PACKAGING –economic way of protecting,
preparing, identifying and containing the drug
• ______________________ –addition of
product
an active in an unstable preparation to
compensate for the loss during Containers
manufacture
Primary
Secondary
Validation is a documented evidence that a
system does what it is supposed to do • additional protection, avenue for
________ (Boxes, Pallets)
1) Accuracy
2) Precision Classification of Containers
3) _________– ability of assay to
discriminate between small differences I) According to Protection Ability
in analyte concentration 1. Well-Closed Container
4) Specificity – ability of assay to
differentiate and quantify the intended • protects against extraneous solids
analyte in the presence of other and loss of drug under ordinary
components expected to be present in conditions of handling, shipment,
storage and distribution
the sample
2. Tight Container
5) Linearity – measured test results are
directly proportional to the • protects from extraneous solids,
concentration of the analyte in the liquids or vapors, from loss of drug
sample within a range of the analyte and from efflorescence,
concentration deliquescence or evaporation and
6) ________ – measurement of an assay’s loss of drug under ordinary
tolerance to small perturbations in one conditions of handling, shipment,
or more components in the assay storage and distribution
3. Hermetic Container
systems
• impervious to air or any other gases
under ordinary conditions of
-all types
4. Rubber
-tests leaching of glass if filled to its filling vol. ,
titrant: 0.01 M HCl
Polyethylene (PE)
Desiccant
- cannot be autoclaved
• Glassine Dapsone
8) Indications *Controlled
Room
9) CI(s), Precation(s), Warning(s) Temperature
10) Direction(s) for use Warm
11) Batch / Lot No(s) Excessive Heat
12) Expiation date
A) Dispensing
B) Milling
C) Mixing
D) Granulation
E) Tableting
F) Coating
G) Encapsulation
A) Dispensing 2) COMPRESSION
b) CONTINUOUS TYPE
• -output: kg/hour
D) Granulation
• Granules – aggregates of
4b) VIBRATION MILL
powders adhered to each other
• -filled to 80% with balls and then the forming larger unit particles
mills is vibrated
• Granules improve: flowability
5) Combined Impact and Attrition and compressibility
• “Fines” Steps:
NOTE:
1)
a)
c) • _______________–discharge takes
place only above the hopper outlet
1) Hopper
2) Punches
Upper punch
Lower punch
3) Cam tracks
1) Diluents/Fillers
4) Dies
5) Feed shoe/frame
6) Receiver
2) Lactose principal bulking agent Ex. talc, corn starch, colloidal silica, calcium
silicate, calcium phosphate, Zn, Mg, and Ca
3) Anhydrous Lactose
stearates
Intermediate Moisture Content Diluents
A- Prevents the adherence of granules to the
1) Mannitol diluents for _________ Punches
sensitive drugs
Ex. colloidal silica, corn starch, sodium lauryl
2) Dextrose sulfate, stearates
a)
2) Binders/Adhesives b)
c)
d)
3) Disintegrants Important Brand Names in the Manufacturing
Practice
a) NUTAB
b) AVICEL
c) CAB-O-SIL
d) VEGETEL
5) Adsorbents
dry
Amaranth #2 _________
Artificial:
Sunset #6 Yellow • saccharin – has bitter aftertaste
Yellow • aspartame – methylester
dipeptide of phenylalanine and
Yellow N/A A pigment used aspartic acid; contraindicated to
Ferric as a component phenylketonurics
Oxide for external • acesulfame K – used more in
applications confectionary
Functions:
F) Tablet Coating
a) For product identification
b) For aesthetic purposes A. Sugar-coating
Steps in Sugar-coating
1. Sealing / Waterproofing
2. Subcoating
3. Syruping / Smoothing
4. Finishing
5. Polishing
7. Glossant
Ex. beeswax
B. Film-coating
Examples: Spansule
Cellulose acetate phthalate Major Tablet Processing Problems
Hydroxypropyl methylcellulose (HPMC) 1. Capping
2. Chipping
2. Alloying Substance
3. Lamination
Ex. polyethylene glycol (PEG)
4. Picking
3. Plasticizer 5. Sticking
7. Weight Variation
4. Surfactant
8. Hardness Variation
Ex. Spans & Tweens
9. Blistering
12. Sweating
Capsule
2. Plasticizer
• solid dosage form in which one or more
medicinal and/or inert substances are • for elasticity & flexibility
enclosed within a small edible shell usually • glycerin, sorbitol
made of gelatin
3. Colorants
Types of Capsules
• FD&C
1. Hard Gelatin Capsule (HCG)
IV) Manufacture of Liquid Dosage Forms 7) Flavors, sweeteners (syrups, etc.), colors,
odorants
Advantages:
• Easier to administer
• More economical
• More bioavailable
Disadvantages
• Less stable
A) SOLUTIONS
Chelating agents
B) EMULSIONS
Types:
1) Anionic
Advantages:
– Polar part (-) charge
• Improved disso and BA of poorly
soluble drugs – Good foamers
4) Amphoteric
– Ex. _________________
• Sedimentation • Viscosity
• Breaking/Cracking • pH
-Oral – NaCMC, tragacanth, acacia, guar gum, V) Manufacture of Sterile Dosage Forms
xanthan gum
STERILE DOSAGE FORMS
-Topical – carbomer (Carbopol®)
a) “Parenteral”
Wetting agents (usually 0.05-0.5%) – allow
-injectable routes of admin. (ex. IV, IM, SC)
displacement of air from hydrophobic material
-IV: 100% BA because _____(?) _____
-HLB value of: _____
-__: most vaccines such as Dengvaxia
-Glycerin, PEG, Syrup
-__: insulin
Flocculating agents (usually <1%) – electrolytes
(ex. NaCl, KCl) b) Ophthalmic preparations
General Manufacturing Steps for Suspension: C) Irrigation solutions
2 Major Requirements
1)
2)
Sources of pyrogens:
Instabilities of a suspension: – Water
• Caking – Containers
• Settling too rapidly – Equipment
• Solubilization of dispersed phase – Solutes (processed with water
not depyrogenated)
• Polymorphism
• not required to be
sterile but required to
be pyrogen-free
• no added substances
Isopropyl myristate
A) Antioxidants
Categories
B) Chelating agents
C) Buffers
D) _____________________
-Sodium Chloride
-Sodium Sulfate
Methods of Sterilization
-Dextrose
• Moist heat (autoclave)
E) Antimicrobials
• Dry heat (Oven)
-Benzalkonium chloride
• Tyndalization (Intermittent steam
-Benzyl alcohol sterilization)
-Parabens • Gas sterilization (EO)
Propyl paraben • Filtration (Membrane filter)
Methyl paraben • Ionizing radiation (Gamma and
Cathode rays)
MOA: _______________
Application:
MOA: _______________
Application:
MOA: Mutation
Application:
Application: